SuperworthLifeStance Health profit margin LFST
Gross, operating and net profit as a share of revenue over the last twelve months, from 2021.
- Net margin, 12 months
- 3.2%
- Operating margin, 12 months
- 4.9%
- Net margin on a year earlier
- +4.4 pts
- Peer median
- 8.8%
Over the twelve months to Jun 30, 2026, LifeStance Health kept 3.2% of its revenue as net profit, with an operating margin of 4.9%.
Five years earlier its net margin was −23.7%.
The median for 10 hospital and care facility stocks of a similar size is 8.8%.
Profit margin over time
Fiscal year by fiscal year
| Fiscal year | Net margin | Operating margin |
|---|---|---|
| FY2025 | 0.7% | 1.7% |
| FY2024 | −4.6% | −2.5% |
| FY2023 | −17.6% | −17.9% |
| FY2022 | −25.1% | −24.5% |
| FY2021 | −51.5% | −42.9% |
| FY2020 | n/a | n/a |
Quarter by quarter
| Quarter | Ended | Net margin, 12 months | Change on a year | Operating margin |
|---|---|---|---|---|
| Q2 FY26 | 3.2% | +4.4 pts | 4.9% | |
| Q1 FY26 | 1.6% | +4.3 pts | 3.0% | |
| Q4 FY25 | 0.7% | +5.3 pts | 1.7% | |
| Q3 FY25 | −0.7% | +7.2 pts | 0.5% | |
| Q2 FY25 | −1.2% | +11.8 pts | −0.0% | |
| Q1 FY25 | −2.8% | +12.9 pts | −1.0% | |
| Q4 FY24 | −4.6% | +13.1 pts | −2.5% | |
| Q3 FY24 | −7.9% | +10.8 pts | −5.4% | |
| Q2 FY24 | −13.1% | +4.1 pts | −12.1% | |
| Q1 FY24 | −15.7% | +4.9 pts | −15.6% | |
| Q4 FY23 | −17.6% | +7.4 pts | −17.9% | |
| Q3 FY23 | −18.7% | +15.1 pts | −20.2% |
Against its peers
Companies in Medical - Care Facilities nearest LifeStance Health's size, closest first, today.
| Company | Profit margin |
|---|---|
| LFSTLifeStance Health | 3.2% |
| CONConcentra Group Holdings Parent | 8.7% |
| SHCSotera Health | 13.4% |
| OPCHOption Care Health | 3.7% |
| NHCNational Healthcare | 9.0% |
| CHEChemed | 10.6% |
| PACSPACS | 4.8% |
| AVAHAveanna Healthcare | 10.6% |
| PRVAPrivia Health | 1.2% |
| ENSGEnsign | 6.9% |
| MDPediatrix Medical | 9.0% |
| Peer median | 8.8% |
Where LifeStance Health ranks
What the profit margin tells you
Profit as a share of revenue at three levels: gross (after making the product), operating (after running the business) and net (after everything, including tax and interest).
Compare within an industry. 10% is superb for a retailer and poor for a software company.
More on LifeStance Health
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.